US Stock MarketDetailed Quotes

AFIB Acutus Medical

Watchlist
  • 0.042
  • -0.006-12.47%
15min DelayTrading May 16 11:19 ET
1.25MMarket Cap-18P/E (TTM)

Acutus Medical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-31.23%-6.95M
35.65%-19.85M
-38.71%25.26M
34.38%-14.01M
-11.71%-25.8M
80.82%-5.3M
69.06%-30.85M
282.49%41.21M
21.48%-21.35M
2.31%-23.1M
Net income from continuing operations
51.99%-2.06M
-106.14%-81.66M
-323.49%-33.77M
35.19%-13.24M
-631.32%-30.38M
89.30%-4.28M
66.34%-39.62M
148.32%15.11M
28.36%-20.43M
119.90%5.72M
Operating gains losses
5.43%-2.51M
83.20%-12.02M
86.92%-4.57M
-252.57%-3.29M
---1.5M
---2.65M
-255,639.29%-71.55M
---34.93M
---934K
----
Depreciation and amortization
2.72%264K
-27.65%874K
23.47%-3.29M
-27.26%1.25M
39.81%2.66M
-86.38%257K
-82.47%1.21M
-354.59%-4.3M
-4.24%1.72M
3.83%1.9M
Other non cash items
-71.38%87K
6.20%70.44M
3.98%69.75M
352.00%113K
123.05%269K
-21.04%304K
41,553.13%66.33M
2,988.49%67.08M
101.57%25K
-1,456.98%-1.17M
Change In working capital
-386.73%-2.92M
135.04%916K
-133.82%-880K
104.60%165K
-82.29%614K
119.96%1.02M
30.99%-2.61M
150.43%2.6M
-34.55%-3.59M
449.75%3.47M
-Change in receivables
-147.84%-819K
170.23%3.63M
58.51%-2.32M
334.68%1.45M
629.58%2.79M
161.37%1.71M
-250.78%-5.17M
-1,103.05%-5.59M
25.75%-617K
143.31%382K
-Change in inventory
-588.03%-1.61M
-3,721.54%-2.48M
95.58%-83K
-108.02%-57K
-191.22%-2.11M
80.69%-234K
98.32%-65K
-0.48%-1.88M
337.79%711K
380.02%2.31M
-Change in prepaid assets
-83.59%117K
-73.25%656K
-96.50%236K
98.30%-12K
-167.62%-281K
120.45%713K
116.42%2.45M
466.11%6.75M
72.50%-704K
-107.52%-105K
-Change in payables and accrued expense
49.90%-487K
-133.50%-412K
-53.43%2.02M
56.29%-1.29M
-117.41%-167K
12.35%-972K
81.42%1.23M
589.67%4.34M
-351.53%-2.96M
278.92%959K
-Change in other current assets
--0
--0
-28.24%-495K
-73.62%43K
338.83%452K
--0
--0
-157.36%-386K
303.75%163K
364.10%103K
-Change in other current liabilities
42.08%-117K
55.55%-473K
62.15%-240K
119.78%36K
63.98%-67K
-225.81%-202K
-90.68%-1.06M
-340.28%-634K
-152.78%-182K
-77.14%-186K
Cash from discontinued investing activities
4.34%-9.98M
25.49%-43.27M
-10.43M
-58.07M
Operating cash flow
-7.64%-16.93M
29.01%-63.12M
-6.81%-18.01M
34.38%-14.01M
33.46%-15.37M
43.03%-15.73M
10.80%-88.92M
25.32%-16.86M
21.48%-21.35M
2.31%-23.1M
Investing cash flow
Cash flow from continuing investing activities
-42.13%8.95M
-44.92%59.77M
-22.17%12.43M
403.68%16.95M
-79.60%14.93M
-3.39%15.46M
469.10%108.51M
239.81%15.97M
195.27%3.37M
234.87%73.17M
Net PPE purchase and sale
-320.00%-105K
3.95%-219K
-47.66%1.18M
45.70%-410K
-52.22%-959K
97.70%-25K
97.71%-228K
166.30%2.25M
-1.21%-755K
70.67%-630K
Net business purchase and sale
-57.06%7.3M
-75.71%17M
--0
--0
--0
--17M
--70M
--20M
--0
--50M
Net investment purchase and sale
215.21%1.75M
10.98%42.99M
279.44%11.26M
321.33%17.36M
-33.24%15.89M
-108.89%-1.52M
33.38%38.73M
21.96%-6.27M
247.88%4.12M
-0.83%23.8M
Cash from discontinued investing activities
Investing cash flow
-39.47%9.23M
-44.10%58.56M
-8.17%11.22M
403.68%16.95M
-79.31%15.14M
-4.69%15.25M
449.41%104.75M
206.95%12.22M
195.27%3.37M
234.87%73.17M
Financing cash flow
Cash flow from continuing financing activities
0
79.48%-2.38M
-144.33%-215K
-322.49%-1.94M
97.95%-238K
109.52%4K
-114.60%-11.62M
194.36%485K
-100.56%-458K
-5,165.94%-11.6M
Net issuance payments of debt
----
--0
--0
--0
----
----
---9.73M
--0
--899K
----
Net common stock issuance
----
--0
661.22%275K
29.41%-12K
----
----
-100.13%-111K
-600.00%-49K
-100.02%-17K
---45K
Proceeds from stock option exercised by employees
--0
-89.68%29K
--0
--0
--25K
-98.39%4K
-75.59%281K
312.50%33K
--0
--0
Net other financing activities
----
-17.08%-2.41M
-197.80%-490K
----
----
----
51.38%-2.06M
197.28%501K
-40.17%-1.34M
-321.72%-932K
Cash from discontinued financing activities
80.65%-42K
-280K
-217K
0
Financing cash flow
80.28%-42K
77.07%-2.66M
-202.06%-495K
-322.49%-1.94M
99.82%-21K
-407.14%-213K
-114.60%-11.62M
194.36%485K
-100.56%-458K
-5,165.94%-11.6M
Net cash flow
Beginning cash position
-16.42%26.2M
29.42%31.35M
-3.23%31.12M
-40.74%30.06M
139.61%29.88M
29.42%31.35M
-4.58%24.22M
-45.17%32.15M
596.95%50.72M
42.00%12.47M
Current changes in cash
-1,018.64%-7.74M
-271.34%-7.23M
-75.15%-7.29M
105.46%1.01M
-100.66%-253K
94.06%-692K
502.87%4.22M
87.95%-4.16M
-135.80%-18.44M
2,561.36%38.47M
Effect of exchange rate changes
--0
-28.53%2.08M
-29.29%2.37M
141.94%52K
294.17%433K
-679.00%-779K
2,607.76%2.91M
3,324.49%3.36M
16.78%-124K
-477.97%-223K
End cash Position
-38.22%18.46M
-16.42%26.2M
-16.42%26.2M
-3.23%31.12M
-40.74%30.06M
139.61%29.88M
29.42%31.35M
29.42%31.35M
-45.17%32.15M
596.95%50.72M
Free cash flow
-8.13%-17.03M
28.95%-63.34M
-15.18%-16.84M
34.77%-14.42M
31.18%-16.33M
45.11%-15.75M
18.70%-89.15M
43.70%-14.62M
20.87%-22.1M
8.00%-23.73M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -31.23%-6.95M35.65%-19.85M-38.71%25.26M34.38%-14.01M-11.71%-25.8M80.82%-5.3M69.06%-30.85M282.49%41.21M21.48%-21.35M2.31%-23.1M
Net income from continuing operations 51.99%-2.06M-106.14%-81.66M-323.49%-33.77M35.19%-13.24M-631.32%-30.38M89.30%-4.28M66.34%-39.62M148.32%15.11M28.36%-20.43M119.90%5.72M
Operating gains losses 5.43%-2.51M83.20%-12.02M86.92%-4.57M-252.57%-3.29M---1.5M---2.65M-255,639.29%-71.55M---34.93M---934K----
Depreciation and amortization 2.72%264K-27.65%874K23.47%-3.29M-27.26%1.25M39.81%2.66M-86.38%257K-82.47%1.21M-354.59%-4.3M-4.24%1.72M3.83%1.9M
Other non cash items -71.38%87K6.20%70.44M3.98%69.75M352.00%113K123.05%269K-21.04%304K41,553.13%66.33M2,988.49%67.08M101.57%25K-1,456.98%-1.17M
Change In working capital -386.73%-2.92M135.04%916K-133.82%-880K104.60%165K-82.29%614K119.96%1.02M30.99%-2.61M150.43%2.6M-34.55%-3.59M449.75%3.47M
-Change in receivables -147.84%-819K170.23%3.63M58.51%-2.32M334.68%1.45M629.58%2.79M161.37%1.71M-250.78%-5.17M-1,103.05%-5.59M25.75%-617K143.31%382K
-Change in inventory -588.03%-1.61M-3,721.54%-2.48M95.58%-83K-108.02%-57K-191.22%-2.11M80.69%-234K98.32%-65K-0.48%-1.88M337.79%711K380.02%2.31M
-Change in prepaid assets -83.59%117K-73.25%656K-96.50%236K98.30%-12K-167.62%-281K120.45%713K116.42%2.45M466.11%6.75M72.50%-704K-107.52%-105K
-Change in payables and accrued expense 49.90%-487K-133.50%-412K-53.43%2.02M56.29%-1.29M-117.41%-167K12.35%-972K81.42%1.23M589.67%4.34M-351.53%-2.96M278.92%959K
-Change in other current assets --0--0-28.24%-495K-73.62%43K338.83%452K--0--0-157.36%-386K303.75%163K364.10%103K
-Change in other current liabilities 42.08%-117K55.55%-473K62.15%-240K119.78%36K63.98%-67K-225.81%-202K-90.68%-1.06M-340.28%-634K-152.78%-182K-77.14%-186K
Cash from discontinued investing activities 4.34%-9.98M25.49%-43.27M-10.43M-58.07M
Operating cash flow -7.64%-16.93M29.01%-63.12M-6.81%-18.01M34.38%-14.01M33.46%-15.37M43.03%-15.73M10.80%-88.92M25.32%-16.86M21.48%-21.35M2.31%-23.1M
Investing cash flow
Cash flow from continuing investing activities -42.13%8.95M-44.92%59.77M-22.17%12.43M403.68%16.95M-79.60%14.93M-3.39%15.46M469.10%108.51M239.81%15.97M195.27%3.37M234.87%73.17M
Net PPE purchase and sale -320.00%-105K3.95%-219K-47.66%1.18M45.70%-410K-52.22%-959K97.70%-25K97.71%-228K166.30%2.25M-1.21%-755K70.67%-630K
Net business purchase and sale -57.06%7.3M-75.71%17M--0--0--0--17M--70M--20M--0--50M
Net investment purchase and sale 215.21%1.75M10.98%42.99M279.44%11.26M321.33%17.36M-33.24%15.89M-108.89%-1.52M33.38%38.73M21.96%-6.27M247.88%4.12M-0.83%23.8M
Cash from discontinued investing activities
Investing cash flow -39.47%9.23M-44.10%58.56M-8.17%11.22M403.68%16.95M-79.31%15.14M-4.69%15.25M449.41%104.75M206.95%12.22M195.27%3.37M234.87%73.17M
Financing cash flow
Cash flow from continuing financing activities 079.48%-2.38M-144.33%-215K-322.49%-1.94M97.95%-238K109.52%4K-114.60%-11.62M194.36%485K-100.56%-458K-5,165.94%-11.6M
Net issuance payments of debt ------0--0--0-----------9.73M--0--899K----
Net common stock issuance ------0661.22%275K29.41%-12K---------100.13%-111K-600.00%-49K-100.02%-17K---45K
Proceeds from stock option exercised by employees --0-89.68%29K--0--0--25K-98.39%4K-75.59%281K312.50%33K--0--0
Net other financing activities -----17.08%-2.41M-197.80%-490K------------51.38%-2.06M197.28%501K-40.17%-1.34M-321.72%-932K
Cash from discontinued financing activities 80.65%-42K-280K-217K0
Financing cash flow 80.28%-42K77.07%-2.66M-202.06%-495K-322.49%-1.94M99.82%-21K-407.14%-213K-114.60%-11.62M194.36%485K-100.56%-458K-5,165.94%-11.6M
Net cash flow
Beginning cash position -16.42%26.2M29.42%31.35M-3.23%31.12M-40.74%30.06M139.61%29.88M29.42%31.35M-4.58%24.22M-45.17%32.15M596.95%50.72M42.00%12.47M
Current changes in cash -1,018.64%-7.74M-271.34%-7.23M-75.15%-7.29M105.46%1.01M-100.66%-253K94.06%-692K502.87%4.22M87.95%-4.16M-135.80%-18.44M2,561.36%38.47M
Effect of exchange rate changes --0-28.53%2.08M-29.29%2.37M141.94%52K294.17%433K-679.00%-779K2,607.76%2.91M3,324.49%3.36M16.78%-124K-477.97%-223K
End cash Position -38.22%18.46M-16.42%26.2M-16.42%26.2M-3.23%31.12M-40.74%30.06M139.61%29.88M29.42%31.35M29.42%31.35M-45.17%32.15M596.95%50.72M
Free cash flow -8.13%-17.03M28.95%-63.34M-15.18%-16.84M34.77%-14.42M31.18%-16.33M45.11%-15.75M18.70%-89.15M43.70%-14.62M20.87%-22.1M8.00%-23.73M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg
Concept Top Gainers Yesterday
Top Gainers Yesterday
Intraday-5.48%